RGC logo

Regencell Bioscience Holdings Limited (RGC) Stock

Profile

Sector:

Healthcare

Country:

Hong Kong

IPO:

16 July 2021

Indexes:

Not included

Description:

Regencell Bioscience Holdings Limited focuses on developing innovative treatments for neurological and psychiatric disorders. The company specializes in research and production of natural therapies, aiming to improve mental health and cognitive function through its unique formulations and advanced scientific methods.

Events Calendar

Earnings

Next earnings date:

June 20, 2025

Recent quarterly earnings:

June 20, 2024

Recent annual earnings:

Oct 29, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

RGC Resources, Inc. Schedules Fourth Quarter 2024 Earnings Call
RGC Resources, Inc. Schedules Fourth Quarter 2024 Earnings Call
RGC Resources, Inc. Schedules Fourth Quarter 2024 Earnings Call
RGC
globenewswire.com25 November 2024

ROANOKE, Va., Nov. 25, 2024 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal fourth quarter and 2024 fiscal year on Thursday, December 5, 2024 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website on the Investor & Financial Information page at https://www.rgcresources.com/investor-financial-information/ .

RGC Resources, Inc. Raises Annual Dividend to $0.83 per Share
RGC Resources, Inc. Raises Annual Dividend to $0.83 per Share
RGC Resources, Inc. Raises Annual Dividend to $0.83 per Share
RGC
globenewswire.com22 November 2024

ROANOKE, Va., Nov. 22, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of RGC Resources, Inc. (Nasdaq: RGCO), at its meeting on November 22, 2024, declared a quarterly dividend of $0.2075 per share on the Company's common stock. The indicated annual dividend is $0.83 per share, a $0.03, or 3.8%, per share increase over the prior annual level. The Company has now increased the annual dividend 21 consecutive years. Paul Nester, CEO of RGC Resources, Inc., stated, “The Roanoke Gas utility continues to deliver solid operational and financial performance. Further, we are pleased that the MVP was completed in 2024 and now delivering affordable, reliable natural gas to Southwest Virginia. This dividend increase, our 21st annual increase, reflects our commitment to deliver long-term shareholder value.” The dividend will be paid on February 1, 2025 to shareholders of record on January 17, 2025. This is the Company's 323rd consecutive quarterly cash dividend.

RGC Resources, Inc. Reports 2024 Earnings
RGC Resources, Inc. Reports 2024 Earnings
RGC Resources, Inc. Reports 2024 Earnings
RGC
globenewswire.com13 November 2024

ROANOKE, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) announced consolidated Company earnings of $11,760,896, or $1.16 per share, for the fiscal year ended September 30, 2024, compared to $11,299,282, or $1.14 per share, for the fiscal year ended September 30, 2023. The increase reflected higher levels of earnings from the Company's investment in the Mountain Valley Pipeline (“MVP”) due to more AFUDC in fiscal 2024 prior to the pipeline being placed in service in June 2024. The lower cost of natural gas in 2024 reduced bills to customers and revenues for the Company, despite inflationary costs leading to higher tariffs. Interest expense also increased primarily due to higher interest rates.

RGC Resources, Inc. Declares Quarterly Dividend
RGC Resources, Inc. Declares Quarterly Dividend
RGC Resources, Inc. Declares Quarterly Dividend
RGC
globenewswire.com30 September 2024

ROANOKE, Va., Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of RGC Resources, Inc. (NASDAQ: RGCO), at its meeting on September 30, 2024, declared a quarterly dividend of $0.20 per share on the Company's common stock. The dividend will be paid on November 1, 2024 to shareholders of record on October 18, 2024. This is the Company's 322nd consecutive quarterly cash dividend.

RGC Resources, Inc. Reports Third Quarter Earnings
RGC Resources, Inc. Reports Third Quarter Earnings
RGC Resources, Inc. Reports Third Quarter Earnings
RGC
globenewswire.com05 August 2024

ROANOKE, Va., Aug. 05, 2024 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) announced consolidated Company earnings of $156,692, or $0.02 per share, for the third quarter ended June 30, 2024, compared to $686,816, or $0.07 per share, for the fiscal quarter ended June 30, 2023. The decline was the result of decreased operating income due to higher personnel and professional costs as well as persistent inflationary pressures across most areas compared to a year ago, along with lower noncash earnings from the Company's investment in the Mountain Valley Pipeline, LLC (“MVP”) as the pipeline transitioned from construction to gas transmission operations.

RGC Resources, Inc. Schedules Third Quarter 2024 Earnings Call
RGC Resources, Inc. Schedules Third Quarter 2024 Earnings Call
RGC Resources, Inc. Schedules Third Quarter 2024 Earnings Call
RGC
globenewswire.com26 July 2024

ROANOKE, Va., July 26, 2024 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal third quarter 2024 on Wednesday, August 7, 2024 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website on the Investor & Financial Information page at https://www.rgcresources.com/investor-financial-information/ .

FAQ

  • What is the primary business of Regencell Bioscience Holdings Limited?
  • What is the ticker symbol for Regencell Bioscience Holdings Limited?
  • Does Regencell Bioscience Holdings Limited pay dividends?
  • What sector is Regencell Bioscience Holdings Limited in?
  • What industry is Regencell Bioscience Holdings Limited in?
  • What country is Regencell Bioscience Holdings Limited based in?
  • When did Regencell Bioscience Holdings Limited go public?
  • Is Regencell Bioscience Holdings Limited in the S&P 500?
  • Is Regencell Bioscience Holdings Limited in the NASDAQ 100?
  • Is Regencell Bioscience Holdings Limited in the Dow Jones?
  • When was Regencell Bioscience Holdings Limited's last earnings report?
  • When does Regencell Bioscience Holdings Limited report earnings?

What is the primary business of Regencell Bioscience Holdings Limited?

Regencell Bioscience Holdings Limited focuses on developing innovative treatments for neurological and psychiatric disorders. The company specializes in research and production of natural therapies, aiming to improve mental health and cognitive function through its unique formulations and advanced scientific methods.

What is the ticker symbol for Regencell Bioscience Holdings Limited?

The ticker symbol for Regencell Bioscience Holdings Limited is NASDAQ:RGC

Does Regencell Bioscience Holdings Limited pay dividends?

No, Regencell Bioscience Holdings Limited does not pay dividends

What sector is Regencell Bioscience Holdings Limited in?

Regencell Bioscience Holdings Limited is in the Healthcare sector

What industry is Regencell Bioscience Holdings Limited in?

Regencell Bioscience Holdings Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Regencell Bioscience Holdings Limited based in?

Regencell Bioscience Holdings Limited is headquartered in Hong Kong

When did Regencell Bioscience Holdings Limited go public?

Regencell Bioscience Holdings Limited's initial public offering (IPO) was on 16 July 2021

Is Regencell Bioscience Holdings Limited in the S&P 500?

No, Regencell Bioscience Holdings Limited is not included in the S&P 500 index

Is Regencell Bioscience Holdings Limited in the NASDAQ 100?

No, Regencell Bioscience Holdings Limited is not included in the NASDAQ 100 index

Is Regencell Bioscience Holdings Limited in the Dow Jones?

No, Regencell Bioscience Holdings Limited is not included in the Dow Jones index

When was Regencell Bioscience Holdings Limited's last earnings report?

Regencell Bioscience Holdings Limited's most recent earnings report was on 20 June 2024

When does Regencell Bioscience Holdings Limited report earnings?

The next expected earnings date for Regencell Bioscience Holdings Limited is 20 June 2025